Literature DB >> 26903282

Clinical characteristics associated with mortality of patients with anaerobic bacteremia.

Takumi Umemura1, Yukihiro Hamada2, Yuka Yamagishi3, Hiroyuki Suematsu2, Hiroshige Mikamo4.   

Abstract

The presence of anaerobes in the blood stream is known to be associated with a higher rate of mortality. However, few prognostic risk factor analyses examining whether a patient's background characteristics are associated with the prognosis have been reported. We performed a retrospective case-controlled study to assess the prognostic factors associated with death from anaerobic bacteremia. Seventy-four patients with anaerobic bacteremia were treated between January 2005 and December 2014 at Aichi Medical University Hospital. The clinical information included drug susceptibility was used for analysis of prognostic factors for 30-day mortality. Multivariate logistic analyses revealed an association between the 30-day mortality rate and malignancy (OR: 3.64, 95% CI: 1.08-12.31) and clindamycin resistance (OR: 7.93, 95% CI: 2.33-27.94). The result of Kaplan-Meier analysis of mortality showed that the 30-day survival rate was 83% in clindamycin susceptible and 38.1% in clindamycin resistant anaerobes causing bacteremia. The result of log-rank test also showed that susceptibility to clindamycin affected mortality (P < 0.001). Our results indicated that malignancy and clindamycin susceptibility could be used to identify subgroups of patients with anaerobic bacteremia with a higher risk of 30-day mortality. The results of this study are important for the early and appropriate management of patients with anaerobic bacteremia.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anaerobe; Anaerobic bacteremia; Blood stream infection; Clindamycin; Prognostic factor

Mesh:

Substances:

Year:  2016        PMID: 26903282     DOI: 10.1016/j.anaerobe.2016.02.007

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  4 in total

1.  Antimicrobial Stewardship Opportunities in Patients with Bacteremia Not Identified by BioFire FilmArray.

Authors:  P Ny; A Ozaki; J Pallares; P Nieberg; A Wong-Beringer
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

2.  Application of MALDI-TOF MS to assess clinical characteristics, risk factors, and outcomes associated with anaerobic bloodstream infection: a retrospective observational study.

Authors:  Tsuyoshi Watanabe; Yuki Hara; Yusuke Yoshimi; Waka Yokoyama-Kokuryo; Yoshiro Fujita; Masamichi Yokoe; Yoshinori Noguchi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-06-09       Impact factor: 3.944

3.  The Importance of the Early and Appropriate Treatment of Anaerobic Bacteremia Patients.

Authors:  Young Ah Kim
Journal:  Infect Chemother       Date:  2016-06-30

4.  In Vitro Efficacy of Antibiotic Combinations with Carbapenems and Other Agents against Anaerobic Bacteria.

Authors:  Takumi Umemura; Mao Hagihara; Takeshi Mori; Hiroshige Mikamo
Journal:  Antibiotics (Basel)       Date:  2022-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.